NCL diseases - clinical perspectives
- PMID: 23602993
- PMCID: PMC4631127
- DOI: 10.1016/j.bbadis.2013.04.008
NCL diseases - clinical perspectives
Abstract
The neuronal ceroid lipofuscinoses (NCLs) are lysosomal storage disorders and together are the most common degenerative brain diseases in childhood. They are a group of disorders linked by the characteristic accumulation of abnormal storage material in neurons and other cell types, and a degenerative disease course. All NCLs are characterized by a combination of dementia, epilepsy, and motor decline. For most childhood NCLs, a progressive visual failure is also a core feature. The characteristics of these symptoms can vary and the age at disease onset ranges from birth to young adulthood. Genetic heterogeneity, with fourteen identified NCL genes and wide phenotypic variability render diagnosis difficult. A new NCL classification system based on the affected gene and the age at disease onset allows a precise and practical delineation of an individual patient's NCL type. A diagnostic algorithm to identify each NCL form is presented here. Precise NCL diagnosis is essential not only for genetic counseling, but also for the optimal delivery of care and information sharing with the family and other caregivers. These aspects are challenging because there are also potential long term complications which are specific to NCL type. Therefore care supported by a specifically experienced team of clinicians is recommended. As the underlying pathophysiological mechanism is still unclear for all NCL forms, the development of curative therapies remains difficult. This article is part of a Special Issue entitled: The neuronal ceroid lipofuscinoses or Batten Disease.
Keywords: Batten; Ceroid; Diagnostic algorithm; Disease classification; NCLs.
Copyright © 2013. Published by Elsevier B.V.
Figures
Similar articles
-
NCL Disorders: Frequent Causes of Childhood Dementia.Iran J Child Neurol. 2013 Winter;7(1):1-8. Iran J Child Neurol. 2013. PMID: 24665282 Free PMC article. Review.
-
Molecular genetics of the NCLs -- status and perspectives.Biochim Biophys Acta. 2006 Oct;1762(10):857-64. doi: 10.1016/j.bbadis.2006.05.006. Epub 2006 May 27. Biochim Biophys Acta. 2006. PMID: 16828266 Review.
-
Human pathology in NCL.Biochim Biophys Acta. 2013 Nov;1832(11):1807-26. doi: 10.1016/j.bbadis.2012.11.014. Epub 2012 Nov 29. Biochim Biophys Acta. 2013. PMID: 23200925 Review.
-
Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.Biochim Biophys Acta. 2013 Nov;1832(11):1827-30. doi: 10.1016/j.bbadis.2013.03.017. Epub 2013 Mar 28. Biochim Biophys Acta. 2013. PMID: 23542453 Review.
-
Molecular genetics of the neuronal ceroid lipofuscinoses.Epilepsia. 1999;40 Suppl 3:29-32. doi: 10.1111/j.1528-1157.1999.tb00896.x. Epilepsia. 1999. PMID: 10446748 Review.
Cited by
-
Top-down and bottom-up propagation of disease in the neuronal ceroid lipofuscinoses.Front Neurol. 2022 Nov 11;13:1061363. doi: 10.3389/fneur.2022.1061363. eCollection 2022. Front Neurol. 2022. PMID: 36438942 Free PMC article.
-
Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy.Neurobiol Dis. 2019 Jul;127:362-373. doi: 10.1016/j.nbd.2019.03.025. Epub 2019 Mar 28. Neurobiol Dis. 2019. PMID: 30928643 Free PMC article.
-
Tissue-specific variation in nonsense mutant transcript level and drug-induced read-through efficiency in the Cln1(R151X) mouse model of INCL.J Cell Mol Med. 2016 Feb;20(2):381-5. doi: 10.1111/jcmm.12744. Epub 2015 Dec 9. J Cell Mol Med. 2016. PMID: 26648046 Free PMC article.
-
Eye involvement in inherited metabolic disorders.Ther Adv Ophthalmol. 2020 Dec 29;12:2515841420979109. doi: 10.1177/2515841420979109. eCollection 2020 Jan-Dec. Ther Adv Ophthalmol. 2020. PMID: 33447730 Free PMC article. Review.
-
Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock.Front Neurosci. 2020 Sep 18;14:580179. doi: 10.3389/fnins.2020.580179. eCollection 2020. Front Neurosci. 2020. PMID: 33071748 Free PMC article. Review.
References
-
- Haltia M. The neuronal ceroid-lipofuscinoses: from past to present. Biochim Biophys Acta. 2006;1762:850–856. - PubMed
-
- Mole SE, Williams R, Goebel HH. Contemporary Neurology Series. Oxford University Press; Oxford: 2011. The neuronal ceroid lipofuscinoses (Batten disease) p. 480.
-
- Kousi M, Lehesjoki AE, Mole SE. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat. 2011;33:42–63. - PubMed
-
- Lebrun AH, Storch S, Ruschendorf F, Schmiedt ML, Kyttala A, Mole SE, Kitzmuller C, Saar K, Mewasingh LD, Boda V, Kohlschutter A, Ullrich K, Braulke T, Schulz A. Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship. Hum Mutat. 2009;30:E651–E661. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous